Alfonso Marhx-Bracho

Dr. Alfonso Marhx-Bracho


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 January 2008 in Child's Nervous System
Verified
Journal Article
Closed access
PDF file
AMAlfonso Marhx-Bracho
Alfonso Marhx-Bracho
FRFernando Rueda-Franco
Fernando Rueda-Franco
ATAbraham Ibarra-De La Torre
Abraham Ibarra-De La Torre
OGOscar García-González
Oscar García-González
LBLeticia Bornstein-Quevedo
Leticia Bornstein-Quevedo
BLBeatriz De León-Bogorge
Beatriz De León-Bogorge

27 August 2021 in Genes
Verified
Journal Article
Open access
PDF file
BHBeatriz Hernández
Beatriz Hernández
FFFabiola Fernández-Rosario
Fabiola Fernández-Rosario
RCRosa Angélica Castillo-Rodríguez
Rosa Angélica Castillo-Rodríguez
AMAlfonso Marhx-Bracho
Alfonso Marhx-Bracho
Noemi Cardenas-RodríguezNoemi Cardenas-Rodríguez
Noemi Cardenas-Rodríguez
SGSaul Gomez-Manzo
Saul Gomez-Manzo
Gliomas are heterogeneous, solid, and intracranial tumors that originate from glial cells. Malignant cells from the tumor undergo metabolic alterations to obtain the energy required for proliferation and the invasion of the cerebral parenchyma. The alterations in the expression of the genes related to the metabolic pathways can be detected in biopsies of gliomas of different CNS WHO grades. In this study, we evaluated the expression of 16 candidate reference genes in the HMC3 microglia cell line. Then, statistical algorithms such as BestKeeper, the comparative ΔCT method, geNorm, NormFinder, and RefFinder were applied to obtain the genes most suitable to be considered as references for measuring the levels of expression in glioma samples. The results show that PKM and TPI1 are two novel genes suitable for genic expression studies on gliomas. Finally, we analyzed the expression of genes involved in metabolic pathways in clinical samples of brain gliomas of different CNS WHO grades. RT-qPCR analysis showed that in CNS WHO grade 3 and 4 gliomas, the expression levels of HK1, PFKM, GAPDH, G6PD, PGD1, IDH1, FASN, ACACA, and ELOVL2 were higher than those of CNS WHO grade 1 and 2 glioma biopsies. Hence, our results suggest that reference genes from metabolic pathways have different expression profiles depending on the stratification of gliomas and constitute a potential model for studying the development of this type of tumor and the search for molecular targets to treat gliomas.

Verified
Journal Article
Open access
PDF file
SNSonia Nava-Salazar
Sonia Nava-Salazar
SGSaul Gomez-Manzo
Saul Gomez-Manzo
JMJaime Marcial-Quino
Jaime Marcial-Quino
AMAlfonso Marhx-Bracho
Alfonso Marhx-Bracho
BPBryan V. Phillips-Farfán
Bryan V. Phillips-Farfán
AVAmerica Vanoye-carlo
America Vanoye-carlo
Cyclophosphamide (CPA) is a pro-drug commonly used in the chemotherapeutic schemes for glioma treatment but has high toxicity and the side effects include brain damage and even death. Since CPA is activated mainly by CY2B6, over-expression of the enzyme in the tumor cells has been proposed to enhance CPA activation. In this study, we explored the induction of the Cyp2b1 (homologous to CYP2B6) by nicotine in an animal rat model with glioma. Gene expression and protein levels were analyzed by RT-PCR and Western blot. Nicotine treatment increased CYP2B1 protein levels in the healthy animals’ brain tissue. In the brain tissue of animals with glioma, the CYP2B1 showed a high expression, even before nicotine treatment. Nicotine did not increase significantly the CYP2B1 protein expression in the tumor, but increased its expression in the tumor vicinity, especially around blood vessels in the cortex. We also explored CY2B6 expression in glioma samples derived from pediatric patients. Tumor tissue showed a variable expression of the enzyme, which could depend on the tumor malignancy grade. Induction of the CYP2B6 in pediatric gliomas with lower expression of the enzyme, could be an alternative to improve the antitumoral effect of CPA treatment.

31 May 2023 in Brain Sciences
Verified
Journal Article
Open access
PDF file
Roberto Garcia-NavarreteRoberto Garcia-Navarrete
Roberto Garcia-Navarrete
AMAlfonso Marhx-Bracho
Alfonso Marhx-Bracho
JTJavier Terrazo-Lluch
Javier Terrazo-Lluch
JPJosé Luis Pérez-Gómez
José Luis Pérez-Gómez
The sphenoid ridge approach (SRA) was initially described as a surgical technique for treating vascular pathologies near the Sylvian fissure. However, limited studies have systematically explored the use of skull base techniques in pediatric patients. This study investigated an extended variation in the sphenoid ridge approach (E-SRA), which systematically removed the pterion, orbital walls (roof and lateral wall), greater sphenoid wing, and anterior clinoid process to access the base of the skull. Objective: This report aimed to evaluate the advantages of the extradural removal of the orbital roof, pterion, sphenoid wing, and anterior clinoid process as a complement to the sphenoid ridge approach in pediatric patients. Patients and Methods: We enrolled 36 patients with suspected neoplastic diseases in different regions. The E-SRA was performed to treat the patients. Patients were included based on the a priori objective of a biopsy or a total gross resection. The surgical time required to complete the approach, associated bleeding, and any complications were documented. Results: Our results demonstrated that the proposed a priori surgical goal, biopsy, or resection were successfully achieved in all cases. In addition, using the E-SRA technique was associated with a shorter operative time, minimal bleeding, and a lower incidence of complications. The most frequently encountered complications were related to dural closure. Conclusions: The extended sphenoid ridge approach represents a safe and effective option for managing intracranial tumors in pediatrics.

7 November 2023 in Iranian Journal of Allergy, Asthma and Immunology
Verified
Journal Article
Closed access
MYMarco Yamazaki-Nakashimada
Marco Yamazaki-Nakashimada
PHPatricia Herrera-Mora
Patricia Herrera-Mora
AMAlfonso Marhx-Bracho
Alfonso Marhx-Bracho
GLGabriela López-Herrera
Gabriela López-Herrera
JBJuan Carlos Bustamante-Ogando
Juan Carlos Bustamante-Ogando
SSSelma Cecilia Scheffler-Mendoza
Selma Cecilia Scheffler-Mendoza
Most patients with X-linked agammaglobulinemia are susceptible to infections, while some cases also suffer from inflammatory or autoimmune complications. We describe a patient with progressive encephalitis who improved after the use of immunomodulatory treatment with corticosteroids, fluoxetine, and nitazoxanide. In most of the cases the evolution of the progressive encephalitis is complicated and catastrophic. Based on our experience and the review of the literature, we propose the use of this combined treatment to control this devastating complication.

1 June 2019 in Journal of Spine Surgery
Verified
Journal Article
Closed access
PDF file
AMAlfonso Marhx-Bracho
Alfonso Marhx-Bracho
JMJuan Esteban Muñoz Montoya
Juan Esteban Muñoz Montoya
NRNadia Pérez Peña Rosas
Nadia Pérez Peña Rosas
GMGabriel Carrillo Marhx
Gabriel Carrillo Marhx
EFEsteban Ramírez Ferrer
Esteban Ramírez Ferrer
Extramedullary intradural tumors constitute up to 25% of the spinal tumors. Commonly, schwannomas that presents with extradural and intradural compromise are called dumbbell-shaped tumor. The thoracic spine is a common localization for these tumors, especially in pediatric population. Given this surgically difficult localization, some classic approaches for spine tumors can be mixed with modified approaches like the costotransversectomy. The main objective of this report is expose three different pediatric cases in which mixed approach (costotransversectomy plus hemilaminectomy) was implemented for thoracic spine dumbbell-shaped schwannoma resection. It was achieved complete surgical resection without major perioperative complications in the three cases.